Author

Xiongbing Zu

Observed names: Xiong-Bing Zu, Xiong-bing Zu

Institutions: Central South University, Hunan Normal University, Hunan Provincial People's Hospital, Xiangya Hospital Central South University

Observed institutions: Central South University, Hunan Normal University, Hunan Provincial People's Hospital, Xiangya Hospital Central South University

ORCID: 0000-0002-2639-7750

Observed ORCID: 0000-0002-2639-7750

OpenAlex ID: A5101784183

Evolving use of social media among Chinese urologists: Opportunity or challenge?

2017 · Xingbo Long, Lin Qi, et al. · PLoS ONE · 29

Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis

2021 · Anze Yu, Kai Guo, et al. · Bioscience Reports · 17

Recurrence of inflammatory myofibroblastic tumor in bladder secondary to prostate treated with laparoscopic radical cystectomy

2012 · Hui-hui Zhang, Fan Qi, et al. · Medical Science Monitor · 15

Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling

2024 · Chunyu Zhang, Jiao Hu, et al. · Cellular & Molecular Biology Letters · 12

Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer

2024 · Dingshan Deng, Jiatong Xiao, et al. · Journal of Hematology & Oncology · 5

Midline Prostatic Cysts Presenting with Chronic Prostatitis or Secondary Infertility and Minimally Invasive Treatment: Endoscopic or Laparoscopic Approach?

2011 · Hui-hui Zhang, Fan Qi, et al. · Surgical Science · 5

Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer

2025 · Luzhe Yan, Haisu Liang, et al. · BMC Cancer · 4

Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer

2024 · Hao Deng, Jinliang Huang, et al. · Biomaterials Research · 3

MA-Net: A multi-attention segmentation network for anisotropic prostate magnetic resonance images

2025 · Zhenglin Yi, Jinbo Chen, et al. · Engineering Applications of Artificial Intelligence · 2

Efficacy and biomarker analysis of neoadjuvant disitamab vedotin combined with immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study.

2024 · Jiao Hu, Luzhe Yan, et al. · Journal of Clinical Oncology · 1

Erratum to “Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer”

2025 · Hao Deng, Jinliang Huang, et al. · Biomaterials Research

Osteopontin as a novel biomarker for the prognosis and clinical pathology of prostate cancer: a systematic review and meta-analysis

2020 · Anze Yu, Kai Xie, et al. · Research Square

[Inflammatory myofibroblastic tumor of the prostate: a case report and review of the literature].

2011 · Hui-Hui Zhang, Shao-Ming Sun, et al. · PubMed

Works count: 13

Citation count: 93

H-index: 5

I10-index: 4